Provided by Tiger Trade Technology Pte. Ltd.

LENSAR Inc

12.39
+0.31002.57%
Post-market: 12.390.00000.00%16:58 EST
Volume:27.91K
Turnover:342.90K
Market Cap:147.99M
PE:-2.85
High:12.46
Open:12.05
Low:12.05
Close:12.08
52wk High:17.31
52wk Low:8.96
Shares:11.94M
Float Shares:8.64M
Volume Ratio:0.50
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3490
EPS(LYR):-2.7265
ROE:-422.35%
ROA:-8.17%
PB:-5.71
PE(LYR):-4.54

Loading ...

LENSAR Inc. Held Annual Shareholder Meeting

Reuters
·
Dec 20, 2025

LENSAR Q3 Net Income USD -3.7 Million

Reuters
·
Nov 20, 2025

BTIG Sticks to Its Hold Rating for LENSAR (LNSR)

TIPRANKS
·
Nov 12, 2025

LENSAR Showcases Robotic Laser Cataract Surgery Innovation in New Corporate Presentation

Reuters
·
Nov 07, 2025

Lake Street Sticks to Its Hold Rating for LENSAR (LNSR)

TIPRANKS
·
Nov 06, 2025

LENSAR Q3 net loss widens

Reuters
·
Nov 06, 2025

LENSAR Inc. reports Q3 revenue of $14.3 million, up 6% from prior year

Reuters
·
Nov 06, 2025

LENSAR Q3 EPS $(0.31) Misses $(0.05) Estimate, Sales $14.316M Miss $17.500M Estimate

Benzinga
·
Nov 06, 2025

LENSAR Q3 Net Income USD -3.7 Million

Reuters
·
Nov 06, 2025

LENSAR Inc. Announces Date for 2025 Annual Stockholders Meeting

Reuters
·
Nov 05, 2025

LENSAR Inc expected to post a loss of 5 cents a share - Earnings Preview

Reuters
·
Nov 03, 2025

BRIEF-LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Sep 03, 2025

Spyglass Pharma Appoints Elizabeth O’farrell to Its Board of Directors

THOMSON REUTERS
·
Aug 19, 2025

LENSAR Inc. Unveils Presentation on Advanced Robotic Laser Cataract Surgery and Growth in Cataract Procedure Market

Reuters
·
Aug 08, 2025

LENSAR Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 08, 2025

LENSAR Q2 Ebitda USD -900 Thousand

THOMSON REUTERS
·
Aug 07, 2025

LENSAR Inc expected to post a loss of 7 cents a share - Earnings Preview

Reuters
·
Aug 04, 2025

LENSAR Inc. Conducted Virtual Special Stockholders Meeting

Reuters
·
Jul 03, 2025

BRIEF-Lensar Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Jul 02, 2025